Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Pentosidine as a Biomarker for Poor Bone Quality...
Chapter

Pentosidine as a Biomarker for Poor Bone Quality and Elevated Fracture Risk

Abstract

The purpose of this chapter is to explore the concept of pentosidine, an advanced glycation end product, as a biomarker of bone quality and bone fragility. Bone quality is a term used to describe the many factors that contribute to fracture risk that are not necessarily captured during clinical fracture assessment. Pentosidine formation in the body requires glycation and oxidation of proteins. In bone, the protein that is most affected is type …

Authors

Pritchard JM; Willett TL

Book title

Biomarkers in Bone Disease

Series

Biomarkers in Disease: Methods, Discoveries and Applications

Pagination

pp. 355-392

Publisher

Springer Nature

Publication Date

2017

DOI

10.1007/978-94-007-7693-7_32